CoChat

The Aβ‐clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain

Kerridge, Caroline, Belyaev, Nikolai D., Nalivaeva, Natalia N., Turner, Anthony J. · 2014 · Journal of Neurochemistry
Cited by 80

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Proteolytic cleavage of the amyloid precursor protein (APP) by the successive actions of β‐ and γ‐secretases generates several biologically active metabolites including the amyloid β‐peptide (Aβ) and the APP intracellular domain (AICD). By analogy with the Notch signalling pathway, AICD has been proposed to play a role in transcriptional regulation. Among the cohort of genes regulated by AICD is the Aβ‐degrading enzyme neprilysin (NEP). AICD binds to the NEP promoter causing transcriptional activation by competitive replacement with histone deacetylases (HDAC s) leading to increased levels of NEP activity and hence increased Aβ clearance. We now show that the Aβ‐clearance protein transthyretin (TTR) is also epigenetically up‐regulated by AICD. Like NEP regulation, AICD derived specifically from the neuronal APP isoform, APP695, binds directly to the TTR promoter displacing HDAC 1 and HDAC 3. Cell treatment with the tyrosine kinase inhibitor Gleevec (imatinib) or with the alkalizing agent NH4 Cl causes an accumulation of ‘functional’ AICD capable of up‐regulating both TTR and NEP, leading to a reduction in total cellular Aβ levels. Pharmacological regulation of both NEP and TTR might represent a viable therapeutic target in Alzheimer's disease. image Amyloid precursor protein (APP) intracellular domain (AICD) regulates expression of the amyloid (Aβ)‐degrading enzyme neprilysin (NEP). The Aβ‐clearance protein transthyretin (TTR) is also epigenetically regulated by AICD, derived specifically from the neuronal APP 695 isoform. Cell treatment with agents up‐regulating ‘functional’ AICD increases production of TTR and NEP and reduces Aβ levels which might represent a viable therapeutic target in Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.12680

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 80

Metadata

Authors
Kerridge, C., Belyaev, N. D., Nalivaeva, N. N., & Turner, A. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2014-03-12
Volume
130
Issue
3
Pages
419-431
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1973415774
Cited by
80
References
4
FWCI
6.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.